Since the very early days of p53 research, the gain of oncogenic activities by some mutant p53 proteins had been suspected as an important factor contributing to cancer progression. Considerable progress towards understanding the biology of mutant p53 has been made during the last years, the quintessence being the realization that the impact of mutant p53 proteins on the transcriptome of a tumor cell is much more global than previously thought. The emerging role of mutant p53 proteins in coordinating oncogenic signaling and chromatin modifying activities reveals an until now unsuspected function of these proteins as important modifiers of the oncogenic transcriptional response. Notwithstanding the fact that the sequencespecific DNA binding activity of mutant p53 proteins is impaired, they are still able to associate with specific loci on DNA by utilizing different mechanisms. The ability to associate with DNA appears to be crucial for the master role of mutant p53 proteins in coordinating oncogenic transcriptional responses.
Introduction
Mutational inactivation of the tumor suppressor p53 is a prominent event in the development of human cancers, with mutations in the TP53 gene being a definitive biomarker of a progressing malignancy. The TP53 mutational spectrum exhibits a marked bias towards missense point mutations targeting certain residues (hotspots) within the p53 core domain, essential for the sequence-specific DNA binding properties of p53 (p53-SSDB). Accordingly, the inability to influence transcription via binding to specific sites responsive to wild-type p53 (wtp53-REs) is a major biochemical defect caused by TP53 hot-spot mutations. Canonical wtp53-REs are typically composed of at least two decamers, called half-sites and following a degenerated p53 consensus sequence (PuPuPuC(A/T)(T/A)GPyPyPy) (El-Deiry et al., 1992) . In addition to the core DNA binding domain (p53-DBD), the C-terminal domain of p53 (p53-CTD) also possesses several DNA binding activities that are based on the recognition of target DNA by structural features rather than the presence of certain sequence motifs. (For the sake of simplicity the sites that are distinct from p53-REs yet bound specifically by wtp53 or by mutant p53 (mutp53) proteins will be termed collectively non-canonical binding sites). The disclosure of the structure of a co-crystal formed by the p53-DBD and a canonical p53 half-site revealed the principal features of the p53-DBD/DNA interface and formed the basis for understanding the structural premises underlying the loss of the sequence-specific transactivation function by mutp53 proteins (Cho et al., 1994) . Since these seminal findings, the understanding of the biology of mutp53 proteins has advanced enormously, the quintessence being the realization that mutp53 proteins are extremely heterogeneous in their structural and possibly also in their biochemical properties (see Joerger and Fersht, 2007 , this issue; reviewed by Sigal and Rotter, 2000) . Underscoring the inequality of structural defects in the core domains of mutp53 proteins, the major activity of the core domain, SSDB, is impaired in individual mutp53 proteins to different degrees, with the severity of SSDB impairment spanning a broad range (see Joerger and Fersht, 2007; Menendez et al., 2007, this issue; Inga et al., 2001; Ang et al., 2006) . However, except for the residual SSDB activity retained by the core domain of some mutp53 proteins, the principles of DNA recognition by mutp53 proteins and the role of mutp53 DNA binding for the oncogenic activities associated with some mutp53 proteins remains far from being clear. In contrast to the firmly established framework of sequence-specific interactions of wtp53 that rely on the co-coordinated activities of the p53-DBD and the p53-CTD, the relative impact of these two domains on the interaction of mutp53 proteins with non-canonical DNA is still ill defined (reviewed by Sigal and Rotter, 2000; Kim and Deppert, 2004) . The major uncertainty concerns the question of whether mutp53 proteins are able to bind DNA specifically despite the SSDB activity of the core domain being lost or impaired. Until now, all attempts to derive a linear consensus sequence for mutp53 binding sites have been largely futile, as genomic sequences associated with mutp53 proteins are notoriously heterogeneous and elude their stratification by sequence homology. However, despite the lack of sequence similarity, the sequences to which mutp53 proteins bind preferentially do exhibit some common features, such as repetitiveness and the propensity to adopt alternative DNA conformations (Weiker et al., 1992; Mu¨ller et al., 1996; Koga and Deppert, 2000; Walter et al., 2005) . It appears that a certain specificity of the interactions of mutp53 proteins with DNA can be realized by versatile modes that either involve intrinsic DNA binding activities of the mutp53 proteins themselves (direct binding), or can be mediated by the interaction of mutp53 proteins with DNA binding proteins (passive targeting). The emerging traits reveal a very complex picture of the interactions of mutp53 proteins with DNA that serve as a nodal component in coupling oncogenic signaling to alterations in chromatin structure.
The attempts to delineate the specific activities underlying the oncogenic functions of mutp53 proteins often are biased by the inclination to think that such 'bad' activities are acquired by oncogenic forms of mutp53 de novo. However, it appears that most biochemical activities supporting gain-of-function properties of oncogenic mutp53 proteins derive from similar activities inherent to wtp53. In this review, we will discuss the modes of mutp53 interactions with DNA, with the emphasis on the possibility that an imbalance between distinct modes of DNA interactions might be the molecular basis underlying the ability of mutp53 to re-direct transcription and, perhaps other metabolic processes on DNA.
Indirect association of mutp53 with DNA Several sequence motifs mediating transcriptional regulation by mutp53 proteins have been identified (Tsutsumi-Ishii et al., 1995; Gualberto et al., 1995; Frazier et al., 1998; Yang et al., 1999; Zalcenstein et al., 2003) , indicating that specific mutp53 response elements (mutp53-REs) may exist. However, the pool of genomic sequences associated with mutp53 proteins is notoriously heterogeneous, and it appears that mutp53 proteins associate with chromatin by distinct modes that either rely on intrinsic DNA binding activities of mutp53 proteins themselves, or can be mediated via the interaction of mutp53 proteins with other DNA binding factors. Therefore, the lack of sequence homology among putative mutp53-REs can be explained at least in part by the fact that the specificity of the association of mutp53 with DNA will be determined by the DNA binding specificity of other factors interacting with mutp53 proteins. Indeed, several binding partners of mutp53 proteins are sequence-specific DNA binding transcription factors recognizing distinct sequence motifs in DNA (Chicas et al., 2000; Sampath et al., 2001; Scian et al., 2004; Di Agostino et al., 2006) . Notably, the association of mutp53 proteins with certain promoters seems to be predominantly determined by the DNA binding properties of the interacting partner (Chicas et al., 2000; Di Agostino et al., 2006) . Supporting the notion, binding sites of mutp53 proteins often overlap with regulatory sequences recognized by other sequence-specific transcription factors. Importantly, such tethering to 'foreign' binding sites is not a truly 'gained' feature of mutp53 proteins as it is also utilized in transcriptional repression by wtp53: by associating with other sequence-specific binding proteins wtp53 can be recruited to the 'foreign' cognate sites, where it interferes with DNA binding and the transcriptional activities of its cargo proteins. Remarkably, the functional outcomes mediated by wtp53 or mutp53 via such an association with non-canonical sites can be diametrically opposite (Imbriano et al., 2005; Scian et al., 2005) , as the very same interacting partners linked with wtp53 in an antagonistic relationship on the other hand were recognized as the cooperating partners of mutp53 proteins. The interaction of wtp53 or mutp53 with some oncogenic transcription factors is a striking example of their inverse functional relationship. The sequence-specific transactivators Ets-1 and NF-Y, implicated in the regulation of cancer-associated genes (reviewed by Pang et al., 1996; Gu et al., 1999; Gilliland, 2001; Oikawa, 2004) , have emerged as important constituents of the mutp53 transcriptome. In contrast to wtp53 which by binding to Ets-1 inhibits its transcriptional activity (Pastorcic and Das, 2000; Gu et al., 2004) , mutp53 proteins cooperate with Ets-1 and augment the transcription of cancerassociated genes by Ets-1 (Sampath et al., 2001 ; our own unpublished data). Similarly, the interaction of mutp53 proteins with the transcription factor NF-Y converts the 'normal' functional outcome of the NF-Y interaction with wtp53. Whereas the interaction of wtp53 with NF-Y inhibits the transcriptional activation of growthpromoting genes regulated by NF-Y via its binding to CCAAT boxes (Imbriano et al., 2005) , mutp53 proteins recruited by NF-Y to such CCAAT sites in contrast augment the transcriptional activation mediated by NF-Y (for details see Strano et al., 2006, this issue) . Notably, all these interactions involve the p53-CTD which accommodates the binding sites of Ets-1, NF-Y and other DNA binding proteins (Koutsodontis et al., 2005) . Considering that hot-spot mutations while targeting the p53-DBD spare the C-terminus, a shift in the relative contribution of these domains to the different modes of interaction with DNA toward those mediated by protein interactions with the p53-CTD is inevitable in mutp53 proteins. Such an imbalance, largely caused by the loss or impairment of p53-SSDB, may be favored in tumor cells expressing high levels not only of mutp53 but also of their respective binding partners with oncogenic activities.
It has long been unclear how a totally opposite outcome could ensue from the interaction of the very same binding partners with wtp53 or mutp53 proteins tethered to the very same DNA sites. Important insight into the mechanisms underlying such 'conversion of wtp53 function' by mutp53 recently was provided by studies assessing the co-regulation of NF-Y responsive G2/M genes by wtp53 or mutp53 proteins in the context of chromatin (Imbriano et al., 2005 However, such complex formation does not influence transcription in the absence of cellular stress, indicating that the recruitment of either wtp53 or mutp53 to DNA per se is only a prerequisite but not the initiating step in the combinatorial control of transcription by NF-Y and p53 proteins. It turns out that wtp53 or mutp53 recruit distinct chromatin modifying activities to the NF-Yregulated promoters, representing the principal distinction in the stress-induced transcriptional responses mediated by wtp53 or by mutp53. These seminal findings reveal a previously unsuspected role of mutp53 in linking oncogenic signaling and chromatin remodeling. As mutp53 proteins are long-lived and available in high amounts in the nucleus, their constitutive association with specific loci mediated by their interaction with sequence-specific DNA binding proteins would render such loci readily suited for a rapid response under stress conditions. The realization that the transcriptional response mediated by oncogenic forms of mutp53 is sensitive to DNA damage and can be activated by some DNA damaging agents (Di Agostino et al., 2006) raises the necessity to stratify different types of DNA damaging agents with respect to their effects on the transcriptional activity of mutp53 proteins. This is a matter of utmost importance considering that most cytotoxic treatments used in the practice of clinical oncology target DNA and activate DNA damage-responsive pathways. As the ability of mutp53 to associate with the promoters of cancer-promoting genes and activate their transcription relies largely on the interaction of mutp53 with DNA binding proteins, it seems plausible that the transcriptional response mediated by oncogenic mutp53 proteins might be suppressed by inhibiting or interfering with such interactions. In this regard, it might be worth recalling earlier observations that synthetic peptides derived from the p53-CTD are able to suppress the growth of tumor cells expressing mutp53. The tumor suppressing effects of the C-terminal p53 peptides were explained by their ability to restore p53-SSDB of the core domain (Selivanova et al., 1997) . This explanation is compatible with the paradigm, widely accepted at that time, of an inhibitory function of the p53-CTD in p53-SSDB (Hupp and Lane, 1994) . However, it is no longer satisfactory in the light of recent findings that the p53-CTD is an auxiliary domain essential for p53-SSDB (Ahn and Prives, 2001; Kim and Deppert, 2003) and might be worth of being re-considered from a different angle. By keeping in mind that the p53-CTD serves as a platform for the binding of several transcription factors recruiting mutp53 to their cognate sites (e.g. NF-Y, Ets-1 and SP-1), it may be that the C-terminal peptides interfere with the interaction of mutp53 with such factors and, consequently with their ability to recruit mutp53 proteins to the chromatin. Whether or not related to the growth-suppressing effects of the Cterminal p53 peptides, such a scenario is worth of being further explored as a strategy to interfere with the oncogenic transcriptional response mediated by mutp53.
Direct binding of mutp53 to DNA
Direct binding of mutp53 proteins to DNA is another important feature of the oncogenic activities of mutp53 that occurs by different modes. One mode derives from the p53-SSDB activity of wt p53 that is affected unequally by different mutations and underlies the residual wtp53-like transcriptional activity preserved in some p53 mutants (see Menendez et al., 2007, this issue) . A distinctly different mode of mutp53:DNA interaction relies on the ability of mutp53 proteins to bind directly and preferentially DNA in a non-linear conformation (reviewed by Kim and Deppert, 2004) . This mode, termed DNA structure-selective binding (p53-DSSB) (reviewed by Kim and Deppert, 2004) , is persistently exhibited by mutp53 proteins in vitro with artificially constructed DNA structures (Go¨hler et al., 2005; Walter et al., 2005) and is operative in vivo as demonstrated with structurally flexible genomic sequences (Koga and Deppert, 2000; Walter et al., 2005) . From such sequences, MAR/SAR sequences and trinucleotide (CTGCAG) repeats had been identified as genomic targets bound by mutp53 in the p53-DSSB mode (reviewed by Kim and Deppert, 2004) . Although the functional significance of the mutp53 interaction with MAR/SAR DNA and (CTGCAG) tracts is still unclear, the notorious structural flexibility of these sequences provides a proof-of principle that selective binding of non-linear DNA is the molecular base of the recognition of DNA by mutp53 proteins. Interestingly, the ability of mutp53 proteins to bind non-canonic DNA structures formed by (CTGCAG) tracts is not unique to mutp53, but derives from the inherent DNA structure-dependent binding (DSDB) activity of wtp53 (Go¨hler et al., 2002; Walter et al., 2005) . Considering that out the formation of hairpin and slipped DNA structures is the underlying mechanism of (CTGCAG) tract instability associated with several neurodegenerative diseases (Sinden et al., 2002) , the finding that wtp53 and mutp53 proteins target (CTGCAG) tracts in a DSSB mode may provide important insights into the emerging connection between wtp53 and neurodegenerative diseases (Bae et al., 2005; Feng et al., 2006) . Whereas an involvement of mutp53 in the pathophysiology of neurodegenerative diseases seems to be rather unlikely, a more intriguing possibility is that the binding of (CTGCAG) tracts by mutp53 proteins could be relevant for establishing specific patterns of chromatin structure in cancer cells. In light of the propensity of (CTGCAG) tracts to function as nucleosome positioning elements (Wang and Griffith, 1995) , and to stimulate the formation of heterochromatin throughout the genome irrespective of chromosomal location (Saveliev et al., 2003) , it is tempting to hypothesize that wtp53 or mutp53 by associating with (CTGCAG) tracts may contribute to the establishment (or maintenance) of a repressive state of the chromatin. Interestingly, heterochromatin protein 1, involved in the propagation of a heterochromatic structure (Lachner et al., 2001) including those formed by (CTGCAG) tracts (Saveliev et al., 2003) , was recently found to mediate the developmental mutp53 actions on DNA E Kim and W Deppert repression of the alpha-fetoprotein gene by wtp53 (Nguyen et al., 2005) . Keeping in mind that the interactions of wtp53 and of mutp53 with DNA appear to intimately connect with chromatin modifying activities (discussed in the previous section), it would be interesting to examine whether the binding of wtp53 or mutp53 contributes to the regulation of chromatin structure via (CTGCAG) tracts and whether such binding may be relevant for regulation of gene expression. These questions are currently addressed in our laboratories (EK and WD), and we hope to have some answers soon. An important feature of these interactions of mutp53 with DNA is that they are relevant also in the absence of genotoxic stress, thereby functionally distinguishing these interactions from the indirect binding of mutp53 proteins via their interaction with other DNA binding proteins.
Although our understanding of the principal features of the interaction of mutp53 proteins with DNA has advanced enormously, the definition of specific molecular criteria for a putative mutp53 consensus binding site is still far away. If a 'typical' mutp53 binding site would exist, it is likely that its sequence should allow for structural transitions of the DNA duplex and the formation of non-canonical DNA structures. It appears that the affinity of mutp53 binding to non-linear DNA structures varies within broad range and depends on the type of structure and, interestingly also on the sequence composition of the DNA structure. For example, we observed that hairpins formed by CTG triplets generally are better binding substrates for mutp53 than those formed by CAG triplets (own unpublished data). Thus, DNA binding of mutp53 is sequence unspecific but not sequence independent. One important implication that follows from the preferential binding of mutp53 proteins to sites of DNA in a non-canonical conformation is that a discrete site occupied by one mutp53 tetramer can be formed by non-adjacent sequences separated by stretches of intervening DNA of variable length. For example, wtp53 and mutp53 proteins bind hairpin structures formed by multiple CTG triplets at a discrete site residing within the stem of the hairpin (Walter et al., 2005) . Further re-enforcing the notion that the tight binding of wtp53 and mutp53 proteins to non-linear DNA is primarily determined by the local architecture of the DNA, not just any part of the stem, but only its base proximal to the junction of the CTG hairpin will be recognized. Hence, from the many triplets comprising discontinuous (CTG)n tracts only those close to the hairpin junction will actually bind wtp53 or mutp53 proteins, whereas the triplets in-between -although chemically identical to the p53-bound triplets -will be unrecognized. The functional unity of physically remote sequences that act as one composite binding site may be obscure if considered in the context of linear DNA. By extending such a scenario to other types of DNA structures formed by sequences not as 'simple' (or homogeneous) as trinucleotide repeats, and/or spanning large regions in linear DNA, like MAR/SAR regions, mutp53 binding sites may appear even more promiscuous. However, when viewed from the 'non-linear' point of view, the significance and necessity of a physical separation of sequences that form non-linear binding site becomes apparent.
Intriguingly, the assembly of p53 tetramers with DNA seems to follow different rules with linear or non-linear DNA: In striking contrast to the strict requirement of two half-sites for the assembly of p53 tetramers with specific DNA in a linear conformation, already a single half-site in non-linear DNA conformation is sufficient to associate with p53 tetramers (Go¨hler et al., 2002) . In light of the view that the formation of a stable complex between a p53 tetramer and a canonical linear binding site requires the binding of each of the p53 dimers to its 'own' half-site via the core domain, the ability of a p53 tetramer to form a stable complex with only one halfsite (in non-linear DNA) remained a puzzle. Excitingly and unexpectedly too, it turns out that the recently determined spatial architecture of the native p53 tetramer perfectly allows a unilateral mode of DNA binding. According to this model, the p53 tetramer resembles a hollow skewed cube. The DNA binding surface formed by the p53-DBD of one dimer is on the surface of the cube, and is located opposite to the DNA binding surface formed by the p53-DBD of the other dimer (Okorokov et al., 2006) . Thereby a p53 tetramer could bind a single half-site by only one of the p53 dimer pairs, if this interaction is further stabilized by an interaction with the adjacent p53-CTD. More importantly however, the unilateral mode of DNA binding suggested by these seminal finding poses no structural constraints for the simultaneous binding of distantly located individual binding sites by the same p53 tetramer. An important implication following from such a mode of DNA binding is that wtp53 and perhaps even more so mutp53 proteins are able to tether distant sites in DNA to close proximity. Such a scenario, previously suggested for the p53-SSDB-dependent DNA looping (Stenger et al., 1994) , might have a much broader application and underlie distinct modes of DNA binding not only of wtp53, but even more so of mutp53 proteins. Furthermore, considering that the binding of mutp53 proteins to structurally flexible DNA (Weiker et al., 1992; Mu¨ller et al., 1996) or unusual DNA structures (Koga and Deppert, 2000; Go¨hler et al., 2005) is mediated jointly by the DNA binding activities of the p53-DBD and the p53-CTD, and that the core domains of mutp53 proteins exhibit considerable structural diversity (Campomenosi et al., 2001; Ang et al., 2006; Joerger et al., 2006) ; see also Joerger and Fersht, 2007, this issue) , it can be expected that the patterns of mutp53-DSDB will vary greatly among mutp53 proteins in terms of their different affinity toward certain types of DNA structures.
Concluding remarks
Accumulating evidence indicates that most if not all oncogenic activities associated with mutp53 proteins are mediated via their interaction with chromatin. Such mutp53 actions on DNA E Kim and W Deppert interactions appear to contribute to the maintenance of specific chromatin structures in cancer cells. An emerging picture reveals that mutp53 proteins occupy a nodal position in the oncogenic signaling network owing to their ability to coordinate chromatin modifying activities and transcription. Mutp53 proteins are remarkably well suited for their nodal roles in shaping and maintaining the transcriptome of a tumor cell: They are long-lived, accumulate in considerable amounts in the nucleus and, apparently, can (re)-direct chromatin modifying activities to multiple-specific loci dispersed throughout the genome. The finding that mutp53 proteins are capable of boosting the transcriptional response by recruiting chromatin modifying activities to specific loci is ground-breaking (Di Agostino et al., 2006; see Strano et al., 2007, this issue) , as it reveals for the first time the magnitude of the impact mutp53 proteins may have on the transcriptome of a tumor cell. It turns out that mutp53 by associating constitutively with non-canonical loci maintains them in a 'poised for action' state in the absence of cellular stress. Upon stress, such loci predisposed to structural reorganization by mutp53 can be converted into a (transcriptionally) active state by chromatin modifying activities recruited by mutp53. Such a scenario delineated for the transactivation function mediated by mutp53 via the interaction with sequence-specific transcription factors may also underlie non-transcriptional activities of mutp53 that may involve direct binding of non-linear DNA by mutp53 proteins. The loss of the p53-SSDB function in mutp53 proteins is offset by the compensatory mechanisms relying on the non-SSDB modes of DNA binding retained by the C-terminal and the core domains of mutp53. Of the latter ones the preferential binding of non-linear DNA by the p53-DSDB mode is prevailing. Understanding the principles underlying the interaction of mutp53 proteins with DNA and/or other components of chromatin will provide the key to understanding the gain-of-function of mutp53 proteins.
